echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Zhongke New Life invites you to participate in the single-cell multi-omics and spatial omics summit

    Zhongke New Life invites you to participate in the single-cell multi-omics and spatial omics summit

    • Last Update: 2022-08-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Announcement | Big coffee gathered for the single-cell multi-omics and spatial omics summit

    Single-cell sequencing technology has also evolved from pure transcriptome sequencing to multi-omics combined analysis, including genome, transcriptome, epigenome and proteome, as well as spatial multi-omics on a single-cell basis
    .
    Observing the multiverse in a single cell is a broader perspective enabled by single-cell multi-omics technology
    .
    Problems such as multi-omics data integration analysis, technological innovation and technological application are also emerging
    .
    Peking University Medical School 110th Anniversary Series Activities - Single-cell Multi-omics and Spatial Omics Online Summit" event
    Lecture Schedule






    For more information, please pay attention to the WeChat public account: Zhongke New Life Protein Metabolism Multiomics!


    Guest introduction
    Bai Fan is currently a researcher/full professor at Peking University Biomedical Frontier Innovation Center (BIOPIC), Beijing Future Genetic Diagnosis Advanced Innovation Center (ICG), and School of Life Sciences
    .
    Bai Fan's laboratory is committed to the innovation and application of single-cell and single-molecule technologies, exploring the frontier and intersecting fields of biomedicine, focusing on the mechanism of cancer occurrence, gene mutation and metastasis, and the molecular mechanism of bacterial pathogenesis and antibiotic resistance
    .
    He has published more than 100 papers in famous academic journals such as Science (2 papers), Nature, Cell (2 papers), Cancer Cell, Nature Immunology, Molecular Cell (2 papers), and won the "Young Overseas High-level Talents" of the Organization Department of the Central Committee of the Communist Party of China.
    Plan, the Fund Committee Outstanding Youth Fund (2017), Outstanding Youth Fund (2021)
    .
    As the project leader, he has won the Ministry of Science and Technology 863 Program, the "Precision Medicine" key research and development program, and major scientific and technological projects for many times.
    Yuanxiehe Innovation Breakthrough Award
    .
    The research results were awarded the 2019 China Annual Paper by Cell Magazine, and the 2019 Top Ten Progress in China's Clinical Medicine
    .


    Ge Gao, Peking University Biomedical Frontier Innovation Center (BIOPIC), Beijing Future Genetic Diagnosis Advanced Innovation Center (ICG), Center for Bioinformatics (CBI) and State Key Laboratory of Protein and Plant Genetic Research, researcher and doctoral supervisor
    .
    The laboratory has long been focusing on the development of new technologies and new methods for bioinformatics.
    Since 2016, more than ten new bioinformatics algorithm software and databases developed independently have been effectively accessed 1.
    4 billion times, and more than half of them are from overseas, ranking among the most self-developed in China.
    Internationally influential bioinformatics ranks; during this period, many research papers were selected into ESI Highly Cited (Top 1%) Paper, Top 10 Bioinformatics Progress in China, Top 10 Bioinformatics Databases in China, China Hot Paper List, Faculty 1000 Very Good Paper, etc.
    , it has been cited more than 16,000 times
    .
    Relevant work has been recognized by domestic and foreign peers, and has been selected as a Clarivate/SCI Global Highly Cited Scholar and Elsevier China Highly Cited Scholar (2020, 2021) for many times
    .
    The laboratory's current research focuses on the development of a new generation of bioinformatics methods and technologies, through the integration and mining of multi-omics big data, to accurately construct and analyze cell regulation maps at the single-cell level and explore its application in biomedicine
    .

     
    Nie Zongxiu, researcher at the Institute of Chemistry, Chinese Academy of Sciences, winner of the National Fund for Distinguished Young Scholars, and a member of the Chinese Academy of Sciences Hundred Talents Program
    .
    The main research directions are particle mass spectrometry construction and small molecule metabolite mass spectrometry
    .
    A variety of particle ionization sources and charge detectors have been designed and developed, an ion trap particle mass spectrometry platform has been constructed, and multi-parameter characterization of micro- and nano-scale particles has been carried out; a particle analysis method based on fingerprint mass spectrometry has been established, and the biological Tissue mass spectrometry imaging has broadened the mass range of mass spectrometry by 8 orders of magnitude, from 10e6 Da of molecular mass spectrometry to 10e14 Da of particle mass spectrometry; a series of new MALDI matrices have been synthesized and discovered, and metabolic small molecule mass spectrometry imaging in various animal models has been obtained
    .
    In recent years, he has published more than 110 papers in journals such as Nature Nanotech.
    , Science Advances, Angew.
    Chem.
    , Anal.
    Chem.
    ,
    etc.
    The work published on Nature Nanotech.
    was written by the magazine and commented on a column in the "News Perspective" of the same period, and was selected for the 10th anniversary issue of Nature Nanotech.
    magazine in 2016
    .
    Authorized 24 Chinese invention patents
    .


    Yu Jiale, head of NGS & single-cell sequencing product line of Zhongke New Life, Ph.
    D.
    in biochemical engineering from East China University of Science and Technology
    .
    After that, he worked in the State Key Laboratory of Microbial Metabolism, Shanghai Jiao Tong University, engaged in functional genomics, synthetic biology and other related research.
    He has published many research papers as the first author and corresponding author in the mainstream SCI journals of bioengineering.

    .
    He is currently the head of the NGS & single-cell sequencing product line of Zhongke New Life, and has long been engaged in multi-omics analysis research and services based on high-throughput sequencing, mass spectrometry, single-cell and other technology platforms
    .


    Yang Tianxing, product manager of the Metabolism Line of Zhongke New Life, is currently responsible for the development, management and application scheme design of metabolomics products in the medical field.
    He has rich scientific research project support and design experience for spatial metabolism, metabolic flux and multi-omics schemes.
    Hundreds of items
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.